# ğŸ“… Daily Report - 2025-10-29

> ç”Ÿç‰©ä¿¡æ¯å­¦ RSS è®¢é˜…æ—¥æŠ¥
> ç­›é€‰å…³é”®è¯ï¼šè‚¿ç˜¤, ç™Œç—‡, tumor, cancer, oncology, carcinoma, leukemia, lymphoma, æµ‹åº, sequencing, RNA-seq, RNAseq, DNA-seq, ChIP-seq, ATAC-seq, Hi-C, å•ç»†èƒ, single.cell, single-cell, scRNA, scDNA, scATAC, 10x, ç©ºé—´è½¬å½•ç»„, ç©ºé—´ç»„å­¦, spatial, spatially, Visium, spatial transcriptomics, åŸºå› ç»„, è½¬å½•ç»„, è›‹ç™½è´¨ç»„, ä»£è°¢ç»„, genome, genomics, transcriptome, transcriptomics, proteome, proteomics, metabolome, metabolomics, ç”Ÿç‰©ä¿¡æ¯, ç”Ÿä¿¡, bioinformatics, computational biology, RåŒ…, R package, Bioconductor, Seurat, Scanpy, è¡¨è§‚é—ä¼ , è¡¨è§‚åŸºå› ç»„, epigenetic, epigenome, methylation, ç”²åŸºåŒ–, histone, ç»„è›‹ç™½, differential expression, å·®å¼‚è¡¨è¾¾, pathway, é€šè·¯, enrichment, å¯Œé›†, clustering, èšç±», trajectory, è½¨è¿¹

---

## ğŸ“Š ä»Šæ—¥æ¦‚è§ˆ

- âœ… å‘½ä¸­æ¡ç›®ï¼š43
- ğŸ“Œ å…³é”®è¯å‘½ä¸­ï¼š498 æ¬¡

---

## ğŸ“° å†…å®¹åˆ—è¡¨

### 1. GSE307143 Single-Cell Atlas of the Tumor Immune Microenvironment Across Syngeneic Murine Models

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€single.cellã€single-cellã€scRNAã€scATACã€Visiumã€genomeã€genomics  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Jia Wang ; Bin Jiang ; Minjuan Deng ; Han YanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe tumor immune microenvironment plays a critical role in tumor progression and responses to immunotherapy. Nevertheless, its cellular complexity and heterogeneity remain incompletely understood. In this study, we employed high-resolution single-cell RNA sequencing on CD45+ immune cells isolated from ten syngeneic murine tumor models, representing seven distinct cancer types under treatment-naÃ¯ve conditions, thereby enabling a comprehensive profiling of tumor-infiltrating immune cells. We classified seven principal immune cell populations and provided an in-depth characterization of T cells, NK/innate lymphoid cells, dendritic cells, monocytes/macrophages, and neutrophils.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307143)

---

### 2. GSE305702 RNA-seq of gubernaculum and testis from wild-type, cetacean INSL3 knock-in, and INSL3 knockout mice across developmental stages

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€carcinomaã€sequencingã€RNA-seqã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€R packageã€Seurat  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Yu Zheng ; Simin Chai ; Cuijuan Zhong ; Yixuan Sun ; Guang YangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThis dataset contains high-throughput RNA sequencing (RNA-seq) data generated from gubernaculum and testis samples of wild-type (WT), cetacean INSL3 knock-in (KI), and INSL3 knockout (KO) mice at selected postnatal developmental stages. The purpose of the study was to investigate the molecular consequences of replacing the endogenous mouse Insl3 coding sequence with the cetacean INSL3 ortholog, and to compare transcriptomic profiles among WT, KI, and KO mice to elucidate the functional role of INSL3 in testicular descent and cryptorchidism. RNA-seq was performed on gubernaculum tissue at postnatal day 8 (P8) and testis tissue at P8, P23, and P40 (with some groups excluded due to degeneration or non-specific damage). The dataset supports integrative analyses of developmental stageâ€“specific and genotypeâ€“specific gene expression changes in reproductive tissues.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305702)

---

### 3. GSE305485 Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€carcinomaã€leukemiaã€scRNAã€scDNAã€scATACã€Seurat  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Alexander A Wurm ; Sandra KÃ¼chlerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWe were interested in transcriptional changes after depletion of MYBL2 in acute myeloid leukemia. Therefore, we utilized THP-1 and NOMO-1 as models, and analyzed global alterations of gene expression.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305485)

---

### 4. GSE302654 In Vitro Modeling of and Automated Drug Screening in Embryonal Brain Tumors Using Tumor-Brain Organoids

**åŒ¹é…å…³é”®è¯**ï¼štumorã€scRNAã€Visiumã€genomeã€genomicsã€Seurat  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Riedel Nicole C. ; Walter Carolin ; de Faria Flavia W. ; Atendorf Lea ; Aust Paula ; GÃ¶bel Carolin ; Verma Archana ; Ballast Annika ; Bedzhov Ivan ; Roy Rajanya ; MÃ¼nter Daniel ; Albert Thomas K. ; RÃ¶ssig Claudia ; Johann Pascal ; von Zezschwitz Barbara ; Sandmann Sarah ; Varghese Julian ; Thomas Christian ; SchÃ¼ller Ulrich ; Bruder Jan M. ; Kerl KorneliusSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensEmbryonal brain tumors (EBTs), arising during early brain development, present significant challenges in understanding pathogenesis and developing of treatments. This study explores the efficacy of forebrain organoid (FBO) models in replicating the complexities of the EBT microenvironment. We established an EBT-forebrain-organoid (TBO) model, incorporating embryonal tumor with multilayered rosettes (ETMR) and atypical teratoid and rhabdoid tumor (ATRT), using a scalable liquid-handling-assisted coaggregation method. Comprehensive characterization, including wholemount immunostaining, immunohisto-chemistry, single-cell RNA sequencing, integration with existing datasets, and automated cell type-specific drug screening, validated the TBO model. TBOs closely mimicked mid-gestational fetal brain environments, and EBTs in FBOs better approximated native intratumoral heterogeneity at both histological and transcriptomic levels than tumor-only 3D approaches. Drug screening in ETMR-FBOs identified promising treatment options, including anthracyclins and triptolide, demonstrating anti-tumoral effects with minimal neurotoxicity. Scalable TBO models that incorporate immature neural microenvironments better recapitulate individual tumor heterogeneity and mark significant progress towards targeted therapy and personalized precision medicine.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302654)

---

### 5. GSE301870 KHSRP depletion in leukemia cells

**åŒ¹é…å…³é”®è¯**ï¼šleukemia  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Qingyu Luo ; Andrew LaneSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensKHSRP was knocked down in CAL-1 cells by CRISPR interference, then RNA-seq was performed in control and KHSRP knockdown cells to assess differentially expressed genes.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301870)

---

### 6. GSE299623 Single cell RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€sequencingã€RNAseqã€single.cellã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€Seurat  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Silvia GonzÃ¡lez MartÃ­nez ; JosÃ© PalaciosSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThis study presents a single-cell RNA sequencing (scRNAseq) analysis of six carcinosarcomas and two normal endometrial samples, profiling over 96,000 cells. By integrating transcriptomic data with inferred copy number variations (CNVs), immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH), we resolve the complex cellular architecture and differentiation dynamics of these tumors. We identify distinct lineage-specific programs and uncover heterologous differentiation trajectoriesâ€”including rhabdomyogenic, osteogenic, and a previously undescribed tenogenic lineage defined by SCX, MKX, and TNMD expression. Our results reveal that carcinosarcomas exhibit multilineage plasticity within their mesenchymal component and highlight the power of single-cell analysis to refine tumor classification and uncover hidden developmental programs.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299623)

---

### 7. GSE293584 RNA-sequencing of SVF-derived preadipocytes and adipocytes from inguinal white adipose tissue of male mice treated with vehicle, CGRPa, NPY, NE, or SP

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€oncologyã€sequencingã€RNA-seqã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€histoneã€pathway  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kyle D Dumont ; Jorge L RuasSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo investigate the effects of sensory neuropeptides on preadipocyte and adipocyte function, we treated cultures with vehicle, calcitonin gene-related peptide-alpha (CGRPa), neuropeptide y (NPY), norepinephrine (NE), or substance P (SP) for 10 hours and collected RNA for RNA-sequencing.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293584)

---

### 8. GSE287673 Cell-free fat extract promotes cornea epithelial repair and restores neurodegeneration via an anti-inflammation pathway

**åŒ¹é…å…³é”®è¯**ï¼šcarcinomaã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Seuratã€Scanpyã€histoneã€pathway  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributor : Yuanhua XieSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCorneal homeostasis is a complex process associated with various ocular pathologies, and the development of therapeutic strategies to promote neuroprotection and tissue regeneration is of great challenge. This study investigated the potential benefits of a cell-free fat extract in ameliorating neurodegenerative changes in laser-induced cornea neurodegeneration and alkali burn-induced epithelial injury mouse models. The cell-free fat extract, rich in bioactive compounds, was administered topically, and its effects on neuro regeneration and epithelial cell proliferation were evaluated. Our results exhibited a robust pro-proliferative effect on corneal epithelial cells, contributing to enhanced tissue regeneration in epithelial repair and significant improvement in neuroprotection, characterized by preserving corneal nerve density and branching complexity. These findings suggest that the application of cell-free fat extract holds promise as a novel therapeutic approach for addressing cornea neurodegeneration, offering neuroprotective effects, and promoting tissue repair. Further investigations into the underlying molecular mechanisms and long-term efficacy are warranted to advance the translational potential of this innovative intervention for ocular health.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287673)

---

### 9. GSE287535 FeaSion Decodes the Regulatory Landscape and Functional Diversity of RNA Polymerase II CTD Phosphorylation

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€Seuratã€Scanpyã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287535)

---

### 10. GSE287317 FeaSion Decodes the Regulatory Landscape and Functional Diversity of RNA Polymerase II CTD Phosphorylation

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€Seuratã€Scanpyã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Junyi Zhu ; Lijun BaoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWe utilize the FeaSion (Feature-Screening-Function) strategy to investigate five known phosphorylation states (pY1, pS2, pT4, pS5, pS7) of RNAPII. Our study demonstrates that mutations at these phosphorylation sites broadly influence transcriptional and co-transcriptional processes. And regulators of these sites involve various biological processes.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287317)

---

### 11. GSE287316 FeaSion Decodes the Regulatory Landscape and Functional Diversity of RNA Polymerase II CTD Phosphorylation

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€Seuratã€Scanpyã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Junyi Zhu ; Lijun BaoSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensWe utilize the FeaSion (Feature-Screening-Function) strategy to investigate five known phosphorylation states (pY1, pS2, pT4, pS5, pS7) of RNAPII. Our study demonstrates that mutations at these phosphorylation sites broadly influence transcriptional and co-transcriptional processes. And regulators of these sites involve various biological processes.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287316)

---

### 12. GSE287315 FeaSion Decodes the Regulatory Landscape and Functional Diversity of RNA Polymerase II CTD Phosphorylation

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€Seuratã€Scanpyã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Junyi Zhu ; Lijun BaoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWe utilize the FeaSion (Feature-Screening-Function) strategy to investigate five known phosphorylation states (pY1, pS2, pT4, pS5, pS7) of RNAPII. Our study demonstrates that mutations at these phosphorylation sites broadly influence transcriptional and co-transcriptional processes. And regulators of these sites involve various biological processes.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287315)

---

### 13. GSE287030 DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation

**åŒ¹é…å…³é”®è¯**ï¼šsingle.cellã€scRNAã€scATACã€genomeã€genomics  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Michael Buck ; Caetano ReiseSousaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusInnate immune receptors often induce activation of conventional dendritic cells (cDCs) and enhance antigen (cross-)presentation, favouring immune responses. DNGR-1 (CLEC9A), a receptor expressed by type 1 cDCs (cDC1s) and implicated in immune responses to viruses and cancer, recognises F-actin exposed on dead cell remnants and promotes cross-presentation of associated antigens. Here, we show that recruitment of phosphatase SHIP1, a process governed by a single amino acid residue adjacent to the signalling motif of the receptor, partly explains how DNGR-1 fails to trigger cDC1 activation in vitro. Substituting this residue converts DNGR-1 into an activating receptor but decreases induction of cross-presentation of dead cell-associated antigens. Introducing the reverse mutation into the related receptor Dectin-1 impairs its activation capacity while enhancing its ability to promote cross-presentation. These findings reveal a functional trade-off in receptor signalling and suggest that DNGR-1 has evolved to prioritise antigen cross-presentation over cellular activation, possibly to minimise inflammatory responses to dead cells.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287030)

---

### 14. GSE285505 Fibroblast-Derived Thrombospondin 2 Shapes the Immune-Exclusionary Environment at Invasive Fronts in Colorectal Cancer [Visium

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€Hi-Cã€scRNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€Seuratã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kosuke Iwane ; Yuki Nakanishi ; Yu Muta ; Yasuhiro Fukui ; Hiroaki KasashimaSeries Type : OtherOrganism : Homo sapiensFibrotic colorectal cancers (CRC) are characterized by immune exclusion driven by activated stroma, particularly by cancer-associated fibroblasts (CAFs). This study aims to describe characteristics of spatial immune landscape of CRCs, which are subtyped by transcriptomic signatures and microsatellite instability.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285505)

---

### 15. GSE285504 Fibroblast-Derived Thrombospondin 2 Shapes the Immune-Exclusionary Environment at Invasive Fronts in Colorectal Cancer [scRNA-seq]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€scRNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€Seuratã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kosuke Iwane ; Yuki Nakanishi ; Mayuki Omatsu ; Nobuyuki Kakiuchi ; Masahiro M Nakagawa ; Yu MutaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusFibrotic colorectal cancers (CRC) are characterized by immune exclusion driven by activated stroma, particularly by cancer-associated fibroblasts (CAFs). We identified that the matricellular protein thrombospondin-2 (THBS2) is highly expressed in the stroma of fibrotic CRCs. We performed orthotopic implantation of CMS4-like mouse tumor organoid (MTO) into WT and Thbs2 KO mice. Tumors developed in Thbs2 KO mice were considerably smaller and exhibited increased CD8 T cell infiltration and higher numbers of apoptotic tumor cells compared with WT mice. Our aim is to elucidate how Thbs2 in tumor microenvironment influences tumor growth.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285504)

---

### 16. GSE285503 Fibroblast-Derived Thrombospondin 2 Shapes the Immune-Exclusionary Environment at Invasive Fronts in Colorectal Cancer [RNA-seq_Human_CRC]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€scRNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€Seuratã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kosuke Iwane ; Yuki Nakanishi ; Yu Muta ; Yasuhiro Fukui ; Hiroaki KasashimaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensFibrotic colorectal cancers (CRC) are characterized by immune exclusion driven by activated stroma, particularly by cancer-associated fibroblasts (CAFs). We identified that the matricellular protein thrombospondin-2 (THBS2) is highly expressed in the stroma of fibrotic CRCs. We performed orthotopic implantation of CMS4-like mouse tumor organoid (MTO) into WT and Thbs2 KO mice. Tumors developed in Thbs2 KO mice were considerably smaller and exhibited increased CD8 T cell infiltration and higher numbers of apoptotic tumor cells compared with WT mice. This study aims to elucidate the interaction between fibrotic CRCs and CAFs by comparing the phenotypic characteristics of bulk tumor tissues and their corresponding CAFs.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285503)

---

### 17. GSE285501 Fibroblast-Derived Thrombospondin 2 Shapes the Immune-Exclusionary Environment at Invasive Fronts in Colorectal Cancer [RNA-seq_Mouse_Tumor]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€scRNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kosuke Iwane ; Yuki Nakanishi ; Yu MutaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusFibrotic colorectal cancers (CRC) are characterized by immune exclusion driven by activated stroma, particularly by cancer-associated fibroblasts (CAFs). We identified that the matricellular protein thrombospondin-2 (THBS2) is highly expressed in the stroma of fibrotic CRCs. We performed orthotopic implantation of CMS4-like mouse tumor organoid (MTO) into WT and Thbs2 KO mice. Tumors developed in Thbs2 KO mice were considerably smaller and exhibited increased CD8 T cell infiltration and higher numbers of apoptotic tumor cells compared with WT mice. Our aim is to elucidate how Thbs2 in tumor microenvironment influences tumor growth.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285501)

---

### 18. GSE285500 Fibroblast Derived Thrombospondin-2 Shapes the Immune-Exclusionary Environment at Invasive Fronts in Colorectal Cancer [RNA-seq_Mouse_CAF]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€scRNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kosuke Iwane ; Yuki Nakanishi ; Yu MutaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusFibrotic colorectal cancers (CRC) are characterized by immune exclusion driven by activated stroma, particularly by cancer-associated fibroblasts (CAFs). We identified that the matricellular protein thrombospondin-2 (THBS2) is highly expressed in the stroma of fibrotic CRCs. We performed orthotopic implantation of CMS4-like mouse tumor organoid (MTO) into WT and Thbs2 KO mice. Tumors developed in Thbs2 KO mice were considerably smaller and exhibited increased CD8 T cell infiltration and higher numbers of apoptotic tumor cells compared with WT mice. Our aim is to elucidate how Thbs2 in tumor microenvironment influences tumor growth.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285500)

---

### 19. GSE285177 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€Hi-Cã€scRNAã€scDNAã€R package  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Mus musculusThis SuperSeries is composed of the SubSeries listed below.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285177)

---

### 20. GSE285176 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer [mouse]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€Hi-Cã€scRNAã€scDNAã€genomeã€R package  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Nadine Bley ; Alexander Rausch ; Markus GlaÃŸ ; Robin RolnikSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusHigh-grade serous ovarian cancer (HGSC) accounts for the vast majority (>70%) of ovarian cancer-associated deaths with minor therapeutic improvements. Among four proposed molecular subtypes of HGSC, the C5 subtype is distinguished by high proliferative potential and elevated immune evasion which is indicated by an unfavorable MHCI/PD-L1 ratio. However, the underlying key drivers of the C5 subtype remained elusive. Here we identify oncofetal RNA-binding proteins (RBPs) promoting the immune evasion of C5-HGSC. The IGF2 mRNA binding protein 1 (IGF2BP1) enhances expression of the E3 ligase MDM2, which induces degradation of IRF1 resulting in reduced MHCI presentation. Concomitantly, IGF2BP1 elevates PD-L1 synthesis by impairing its microRNA-directed silencing. This shifts the intra-tumoral MHCI/PD-L1 ratio, limits immune cell infiltration, and promotes evasion of tumor cells from cytotoxic T cells (CTLs) in human and syngeneic mouse models of ovarian cancer. The small molecule inhibitor BTYNB impairs IGF2BP1-directed regulation of MHCI/PD-L1 ratios, promotes CTL-directed killing as well as activation, and strongly synergizes with immune checkpoint inhibition (ICI) by Nivolumab in vitro and in vivo.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285176)

---

### 21. GSE285175 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer [HGSC]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€Hi-Cã€scRNAã€scDNAã€R package  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Nadine Bley ; Alexander Rausch ; Markus GlaÃŸSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHigh-grade serous ovarian cancer (HGSC) accounts for the vast majority (>70%) of ovarian cancer-associated deaths with minor therapeutic improvements. Among four proposed molecular subtypes of HGSC, the C5 subtype is distinguished by high proliferative potential and elevated immune evasion which is indicated by an unfavorable MHCI/PD-L1 ratio. However, the underlying key drivers of the C5 subtype remained elusive. Here we identify oncofetal RNA-binding proteins (RBPs) promoting the immune evasion of C5-HGSC. The IGF2 mRNA binding protein 1 (IGF2BP1) enhances expression of the E3 ligase MDM2, which induces degradation of IRF1 resulting in reduced MHCI presentation. Concomitantly, IGF2BP1 elevates PD-L1 synthesis by impairing its microRNA-directed silencing. This shifts the intra-tumoral MHCI/PD-L1 ratio, limits immune cell infiltration, and promotes evasion of tumor cells from cytotoxic T cells (CTLs) in human and syngeneic mouse models of ovarian cancer. The small molecule inhibitor BTYNB impairs IGF2BP1-directed regulation of MHCI/PD-L1 ratios, promotes CTL-directed killing as well as activation, and strongly synergizes with immune checkpoint inhibition (ICI) by Nivolumab in vitro and in vivo.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285175)

---

### 22. GSE284083 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer [polyA RNA-seq, unsorted co-cultures]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€spatialã€R packageã€Seuratã€Scanpy  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Nadine Bley ; Alexander Rausch ; Danny MisiakSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHigh-grade serous ovarian cancer (HGSC) accounts for the vast majority (>70%) of ovarian cancer-associated deaths with minor therapeutic improvements. Among four proposed molecular subtypes of HGSC, the C5 subtype is distinguished by high proliferative potential and elevated immune evasion which is indicated by an unfavorable MHCI/PD-L1 ratio. However, the underlying key drivers of the C5 subtype remained elusive. Here we identify oncofetal RNA-binding proteins (RBPs) promoting the immune evasion of C5-HGSC. The IGF2 mRNA binding protein 1 (IGF2BP1) enhances expression of the E3 ligase MDM2, which induces degradation of IRF1 resulting in reduced MHCI presentation. Concomitantly, IGF2BP1 elevates PD-L1 synthesis by impairing its microRNA-directed silencing. This shifts the intra-tumoral MHCI/PD-L1 ratio, limits immune cell infiltration, and promotes evasion of tumor cells from cytotoxic T cells (CTLs) in human and syngeneic mouse models of ovarian cancer. The small molecule inhibitor BTYNB impairs IGF2BP1-directed regulation of MHCI/PD-L1 ratios, promotes CTL-directed killing as well as activation, and strongly synergizes with immune checkpoint inhibition (ICI) by Nivolumab in vitro and in vivo.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284083)

---

### 23. GSE283700 RNA-sequencing of SVF-derived preadipocytes from inguinal adipose tissue of male mice differentiating under control conditions or treated with CGRP

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€sequencingã€RNA-seqã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€epigenetic  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Kyle D Dumont ; Jorge L RuasSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo investigate the effects of CGRP on adipocyte differentiation, we treated stromal vascular fraction (SVF)-derived preadipocytes from inguinal white adipose tissue (iWAT) of male mice with CGRP during differentiation. RNA-sequencing was performed across a full time course of normal differentiation to identify transcriptional changes induced by CGRP treatment compared to control conditions.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283700)

---

### 24. GSE281124 Loss of METTL3 potentiates transposable element expression and drives inflammation-induced cell plasticity in the mammary epithelium

**åŒ¹é…å…³é”®è¯**ï¼šscDNAã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€metabolome  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281124)

---

### 25. GSE273025 Patient-derived Induced Pluripotent Stem Cells with a C9orf72 Expansion as a Model to Study Frontotemporal Dementia Pathologies

**åŒ¹é…å…³é”®è¯**ï¼štumorã€scRNAã€scDNAã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€histoneã€enrichmentã€clustering  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Sonia Infante-Tadeo ; Diane L BarberSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe neurodegenerative disorder Frontotemporal Dementia (FTD) can be caused by a repeat expansion (GGGGCC; G4C2) in C9orf72. The function of wild-type C9orf72 and the mechanism by which the C9orf72-G4C2 mutation alteration causes FTD, however, remain unresolved. Diverse disease models including human brain samples and differentiated neurons from patient-derived induced pluripotent stem cells (iPSCs) identified some hallmarks associated with FTD, but these models have limitations, including biopsies capturing only a static snapshot of dynamic processes and differentiated neurons being labor-intensive, costly, and post-mitotic. We find that patient-derived iPSCs, without being differentiated into neurons, exhibit established FTD hallmarks, including increased lysosome pH, decreased lysosomal cathepsin activity, cytosolic TDP-43 proteinopathy, and increased nuclear TFEB. Moreover, lowering lysosome pH in FTD iPSCs mitigates TDP-43 proteinopathy, suggesting a key role for lysosome dysfunction. RNA-seq reveals dysregulated transcripts in FTD iPSCs affecting calcium signaling, cell death, synaptic function, and neuronal development. We confirm differences in protein expression for some dysregulated genes not previously linked to FTD, including CNTFR (neuronal survival), Annexin A2 (anti-apoptotic), NANOG (neuronal development), and moesin (cytoskeletal dynamics). Our findings underscore the potential of FTD iPSCs as a model for studying FTD cellular pathology and for drug screening to identify therapeutics  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273025)

---

### 26. GSE270073 In vivo intratumoral Heterogeneity in a dish: Scalable Forebrain Organoid Models of Embryonal Brain Tumors for High-Throughput Personalized Drug Discovery

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€oncologyã€Hi-Cã€scRNAã€scDNAã€scATACã€Visiumã€genomeã€genomicsã€metabolomeã€Seuratã€Scanpyã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270073)

---

### 27. GSE249898 Multidimensional analysis reveals innate and adaptive immune features associated with toxicities in patients receiving checkpoint inhibitor therapy

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€Seuratã€Scanpyã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : David E Gerber ; Shaheen KhanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAnalysis of 162 patients revealed that individuals who developed clinically significant irAEs exhibited a baseline proinflammatory, autoimmune-like state characterized by a significantly higher abundance of CD57+ T and natural killer (NK) T cells, plasmablasts, proliferating and activated CXCR3+ lymphocytes, CD8+ effector and terminal effector memory T cells, along with reduced NK cells and elevated plasma ANA levels. In irAE cases, we identified distinct baseline proinflammatory gene signatures, including markedly higher expression of IL1B and CXCL8 in monocytes and CXCR3, TNF, and IFNG in T/NK cells. TNF signaling was the most enriched pathway, while immunosuppressive genes SIGLEC7 and CXCR4 were downregulated. Following ICI initiation, these patients exhibited an enhanced shift toward an activated and inflammatory immune phenotype, including monocyte reprogramming characterized by upregulation of IL18 and elevated gene expression levels of CXCL10. Conversely, post-treatment levels of CXCL8 were decreased in irAE patients. Notably, in patients who did not develop clinically significant irAE, we identified increased baseline abundance of a TGFBIhigh myeloid cluster enriched in immunosuppressive markers such as STAB1. In addition, patients without irAE exhibited upregulation of TNF and AIRE, accompanied by distinct myeloid protumorigenic reprogramming.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249898)

---

### 28. GSE234708 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€Hi-Cã€scRNAã€scDNAã€R package  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencing ; Non-coding RNA profiling by high throughput sequencingOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234708)

---

### 29. GSE234707 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer [small RNA-seq]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€spatialã€genomeã€R package  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Nadine Bley ; Alexander Rausch ; Danny MisiakSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Homo sapiensHigh-grade serous ovarian cancer (HGSC) accounts for the vast majority (>70%) of ovarian cancer-associated deaths with minor therapeutic improvements. Among four proposed molecular subtypes of HGSC, the C5 subtype is distinguished by high proliferative potential and elevated immune evasion which is indicated by an unfavorable MHCI/PD-L1 ratio. However, the underlying key drivers of the C5 subtype remained elusive. Here we identify oncofetal RNA-binding proteins (RBPs) promoting the immune evasion of C5-HGSC. The IGF2 mRNA binding protein 1 (IGF2BP1) enhances expression of the E3 ligase MDM2, which induces degradation of IRF1 resulting in reduced MHCI presentation. Concomitantly, IGF2BP1 elevates PD-L1 synthesis by impairing its microRNA-directed silencing. This shifts the intra-tumoral MHCI/PD-L1 ratio, limits immune cell infiltration, and promotes evasion of tumor cells from cytotoxic T cells (CTLs) in human and syngeneic mouse models of ovarian cancer. The small molecule inhibitor BTYNB impairs IGF2BP1-directed regulation of MHCI/PD-L1 ratios, promotes CTL-directed killing as well as activation, and strongly synergizes with immune checkpoint inhibition (ICI) by Nivolumab in vitro and in vivo.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234707)

---

### 30. GSE234706 Targeting IGF2BP1 Enhances Immune Checkpoint Therapy in High-grade Serous Ovarian Cancer [polyA RNA-seq, sorted co-cultures]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€spatialã€R packageã€Seuratã€Scanpy  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Nadine Bley ; Alexander Rausch ; Danny MisiakSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHigh-grade serous ovarian cancer (HGSC) accounts for the vast majority (>70%) of ovarian cancer-associated deaths with minor therapeutic improvements. Among four proposed molecular subtypes of HGSC, the C5 subtype is distinguished by high proliferative potential and elevated immune evasion which is indicated by an unfavorable MHCI/PD-L1 ratio. However, the underlying key drivers of the C5 subtype remained elusive. Here we identify oncofetal RNA-binding proteins (RBPs) promoting the immune evasion of C5-HGSC. The IGF2 mRNA binding protein 1 (IGF2BP1) enhances expression of the E3 ligase MDM2, which induces degradation of IRF1 resulting in reduced MHCI presentation. Concomitantly, IGF2BP1 elevates PD-L1 synthesis by impairing its microRNA-directed silencing. This shifts the intra-tumoral MHCI/PD-L1 ratio, limits immune cell infiltration, and promotes evasion of tumor cells from cytotoxic T cells (CTLs) in human and syngeneic mouse models of ovarian cancer. The small molecule inhibitor BTYNB impairs IGF2BP1-directed regulation of MHCI/PD-L1 ratios, promotes CTL-directed killing as well as activation, and strongly synergizes with immune checkpoint inhibition (ICI) by Nivolumab in vitro and in vivo.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234706)

---

### 31. Elevate Your Data Skills with Jumping Rivers Training

**åŒ¹é…å…³é”®è¯**ï¼šVisium  
**æ¥æº**ï¼šR-blogs  
**ä½œè€…**ï¼šTue, 28 Oct 2025 23:59:00 +0000  
**å‘å¸ƒæ—¶é—´**ï¼šIn todayâ€™s data-driven world, strong analytical and programming skills are essential for success. Whether youâ€™re just starting your data journey or looking to expand your expertise, Jumping Rivers offers training that combines real-world experien... Continue reading: Elevate Your Data Skills with Jumping Rivers Training  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](https://www.r-bloggers.com/2025/10/elevate-your-data-skills-with-jumping-rivers-training/)

---

### 32. September 2025 Top 40 New CRAN Packages

**åŒ¹é…å…³é”®è¯**ï¼šscRNAã€R package  
**æ¥æº**ï¼šR-blogs  
**ä½œè€…**ï¼šTue, 28 Oct 2025 00:00:00 +0000  
**å‘å¸ƒæ—¶é—´**ï¼šComputational Methods fastfocal v0.1.3: Provides a fast moving-window (â€œfocalâ€) and buffer-based extraction for raster data using the terra package. Automatically selects between a C++ backend and a Fast Fourier Transform (FFT) backend depend... Continue reading: September 2025 Top 40 New CRAN Packages  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](https://www.r-bloggers.com/2025/10/september-2025-top-40-new-cran-packages/)

---

### 33. GSE309119 Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy.

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€leukemiaã€scRNAã€scDNAã€genomeã€Seuratã€Scanpyã€enrichment  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Miriam M Fonseca ; Oriana Gelblung ; Sarah D Pennypacker ; Taylor Brooks ; Michael Limia ; James W Morgan ; Xuewei Zhu ; Luis C Tovias-Sanchez ; Alejandro Pluma-Pluma ; Ruth Elena Martinez ; Mathew Eber ; Sun Park ; Cristina M Furdui ; Deepika Awasthi ; Alexander Emmanuelli ; Byuri A Cho ; Chen Tan ; David I Shalowitz ; Samuel S Lentz ; Michael Kelly ; Anderson O Cox ; Lindsay Macnamara ; Fang-Chi Hsu ; Yusuke Shiozawa ; Wesley Hsu ; Takao Iwawaki ; Lance D Miller ; Glenn J Lesser ; Roy Strowd ; Juan R Cubillos-Ruiz ; Edgar A Romero-SandovalSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusChemotherapy-induced peripheral neuropathy (CIPN) is the most prevalent and limiting side effect of paclitaxel treatment in cancer patients. CIPN affects sensory neurons through neuroinflammatory mechanisms, but how immune cells sense and interpret systemic paclitaxel exposure during treatment is unclear. Here, we report that paclitaxel administration triggers the endoplasmic reticulum (ER) stress sensor inositol-requiring enzyme 1Î± (IRE1Î±) in circulating and dorsal root ganglia-resident myeloid cells, engendering an inflammatory milieu that promotes CIPN. Mechanistically, paclitaxel induced overproduction of mitochondrial-derived reactive oxygen species (ROS) that provoked ER stress and IRE1Î± hyperactivation in macrophages. This process reprogrammed macrophages towards a highly inflammatory state characterized by IRE1Î±-dependent production of TNF-Î±, IL-1Î², PGE2, IL-6, IL-5, GM-CSF, MCP-1, and MIP-2. Ablation of IRE1Î± in leukocytes, or treatment with a selective IRE1Î± pharmacological inhibitor, prevented dorsal root ganglia neuroinflammation and CIPN-related pain behaviors in mice. Furthermore, the development and severity of CIPN in patients with gynecological cancer was associated with the status of IRE1Î± activation in their circulating leukocytes. Our study uncovers leukocyte-intrinsic IRE1Î± as a key mediator of CIPN and suggests that targeting its dysregulated activation could help mitigate CIPN in cancer patients receiving paclitaxel.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309119)

---

### 34. GSE280689 Modeling SMAD2 mutations in iPSCs provides insights into cardiovascular disease pathogenesis [RNA-seq]

**åŒ¹é…å…³é”®è¯**ï¼šRNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€Seuratã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Tarsha Ward ; Warren Tai ; Sarah Morton ; Joshua Gorham ; Christine Seidman ; J.G. SeidmanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensRationale: SMAD2 is a co-regulator that binds a variety of transcription factors and modulates activities during human development. Heterozygous SMAD2 loss-of-function (LoF) variants and missense variants are identified in patients with complex congenital heart disease (CHD), and in patients with arterial aneurysms and dissections. Mechanisms that account for distinct cardiovascular phenotypes caused by SMAD2 variants remain unknown. We aimed to define the transcriptional and epigenetic effects of heterozygous SMAD2 loss-of-function (LoF) and missense variants and identify the involvement of transcription factor networks and genes that contribute to CHD. Compared to LoF variants, we assessed the function of rare SMAD2 missense variants of uncertain significance. Methods: We constructed isogenic induced pluripotent stem cells (iPSCs) with heterozygous or homozygous LoF and rare (MAF â‰¤ 10-5) missense SMAD2 variants identified in CHD probands. Wildtype and mutant iPSCs were studied by bulk RNA sequencing (RNAseq) and chromatin accessibility (ATACseq). Datasets were integrated with published SMAD2/3 chromatin immunoprecipitation (ChIPseq) studies. Cardiomyocyte differentiation and contractility of mutant iPSCs was assessed. Results: SMAD2 haploinsufficiency reduced open chromatin across promoter regions and altered the expression of 385 direct SMAD regulated genes, including ten previously identified as dominant CHD genes. Motif analyses in regions with differential ATAC peaks predicted that SMAD2 haploinsufficiency disrupts interactions with at least five transcription factors, NANOG, ETS, TEAD3/4, CREB1 and AP1. Compared to SMAD2-haploinsufficient cells, iPSCs with heterozygous R114C or W274C variants exhibited shared and distinct patterns of altered chromatin accessibility, transcription factor binding motifs, and dysregulated genes. Conclusions: SMAD2 haploinsufficiency disrupts chromatin interactions and perturbs transcription factor binding, disrupting normal cardiovascular development. Differences in the molecular consequences of LoF and missense variants likely contribute to clinical phenotypic heterogeneity. Additionally, these data indicate opportunities for molecular functional analyses to improve re-classification of SMAD2 variants of uncertain clinical significance.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280689)

---

### 35. GSE280646 Stress controls heterochromatin inheritance through histone H3 ubiquitylation [ChIP-Seq]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€RNA-seqã€RNAseqã€ChIP-seqã€ATAC-seqã€scRNAã€scATACã€genomeã€genomicsã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Bharat Bhatt ; Yi Wei ; Ashis Pradhan ; Jothy Dhakshnamoorthy ; Martin Zofall ; Hua Xiao ; Drisya Vijayakumari ; Shweta Jain ; Hernan D Folco ; Hongyun Qi ; David A Ball ; Tatiana S Karpova ; David Wheeler ; Jiemin Wong ; Shiv I GrewalSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Schizosaccharomyces pombeHeterochromatin, marked by histone H3 lysine 9 methylation, can be inherited through cell divisions, maintaining gene repression that preserves cell identity and enables adaptation to environmental challenges. Studies in S. pombe have shown that heterochromatin propagation depends on the read-write mechanism wherein sufficient density of H3K9me3-modified nucleosomes, stabilized by histone deacetylases (HDACs), concentrate Clr4SUV39H on chromatin to promote further deposition of H3K9 methylation. Whether additional mechanisms control heterochromatin propagation via Clr4SUV39H, a part of the E3 ubiquitin ligase complex ClrC, was unknown. Here we uncover a ubiquitin-dependent heterochromatin-heritability regulatory hub (HRH) that broadly governs heterochromatin propagation, even without HDAC activity. The HRH is tuned by the limiting factor Raf1DDB2, a substrate receptor for ClrC ubiquitin ligase. In addition to linking Clr4SUV39H to other ClrC components on chromatin, Raf1DDB2 acts in a dosage-dependent manner to promote ubiquitination of histone H3 at lysine 14 (H3K14ub), which is critical for heterochromatin self-propagation. Importantly, HRH is intricately linked to environmentally responsive pathways, including nonsense-mediated decay (NMD) and TOR signaling, allowing cells to adapt to changing conditions. By modulating heterochromatin propagation, cells leverage the HRH to gain resistance to antifungal agents and to adapt to high temperature. Thus, heterochromatin self-propagation is actively regulated by the HRH in response to external stimuli, with broad implications for understanding mechanisms governing rapid changes in the epigenetic landscape in physiology and disease.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280646)

---

### 36. GSE280607 Stress controls heterochromatin inheritance through histone H3 ubiquitylation [RNA-Seq]

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€RNA-seqã€RNAseqã€ATAC-seqã€scRNAã€scATACã€genomeã€genomicsã€methylationã€histone  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Bharat Bhatt ; Yi Wei ; Ashis Pradhan ; Jothy Dhakshnamoorthy ; Martin Zofall ; Hua Xiao ; Drisya Vijayakumari ; Shweta Jain ; Hernan D Folco ; Hongyun Qi ; David A Ball ; Tatiana S Karpova ; David Wheeler ; Jiemin Wong ; Shiv I GrewalSeries Type : Expression profiling by high throughput sequencingOrganism : Schizosaccharomyces pombeHeterochromatin, marked by histone H3 lysine 9 methylation, can be inherited through cell divisions, maintaining gene repression that preserves cell identity and enables adaptation to environmental challenges. Studies in S. pombe have shown that heterochromatin propagation depends on the read-write mechanism wherein sufficient density of H3K9me3-modified nucleosomes, stabilized by histone deacetylases (HDACs), concentrate Clr4SUV39H on chromatin to promote further deposition of H3K9 methylation. Whether additional mechanisms control heterochromatin propagation via Clr4SUV39H, a part of the E3 ubiquitin ligase complex ClrC, was unknown. Here we uncover a ubiquitin-dependent heterochromatin-heritability regulatory hub (HRH) that broadly governs heterochromatin propagation, even without HDAC activity. The HRH is tuned by the limiting factor Raf1DDB2, a substrate receptor for ClrC ubiquitin ligase. In addition to linking Clr4SUV39H to other ClrC components on chromatin, Raf1DDB2 acts in a dosage-dependent manner to promote ubiquitination of histone H3 at lysine 14 (H3K14ub), which is critical for heterochromatin self-propagation. Importantly, HRH is intricately linked to environmentally responsive pathways, including nonsense-mediated decay (NMD) and TOR signaling, allowing cells to adapt to changing conditions. By modulating heterochromatin propagation, cells leverage the HRH to gain resistance to antifungal agents and to adapt to high temperature. Thus, heterochromatin self-propagation is actively regulated by the HRH in response to external stimuli, with broad implications for understanding mechanisms governing rapid changes in the epigenetic landscape in physiology and disease.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280607)

---

### 37. GSE280216 Difference analysis of microRNAs in abdominal aorta of ApoE-/- AngII-induced abdominal aortic aneurysm mices

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€Scanpy  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Qingbin Hou ; Xiaozeng Wang ; Chenghui Yan ; Yaling HanSeries Type : Non-coding RNA profiling by arrayOrganism : Mus musculusAbdominal aortic aneurysm (AAA) is a vascular disease with high incidence at present.There is no effective drug treatment. MicroRNAs(miRNAs) play a regulatory role in the occurrence and development of AAA,and miRNA therapy is a promising treatment for AAA. The purpose of this study was to explore the differential expression of miRNAs in abdominal aorta of ApoE-/- AngII-induced abdominal aortic aneurysm mices. We used miRNA array to analyze miRNA differences in abdominal aorta between mices with ApoE-/- AngII-induced abdominal aortic aneurysm and ApoE-/-.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280216)

---

### 38. GSE279582 Adar1 as a placental innate immune rheostat to prevent endogenous dsRNA-induced integrated stress response-dependent embryonic lethality [Adar1 PKO RNA-seq]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe mechanisms that balance a robust antiviral defense with tissue tolerance at the maternal-fetal interface under physiological conditions remain largely unknown.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279582)

---

### 39. GSE279579 Adar1 as a placental innate immune rheostat to prevent endogenous dsRNA-induced integrated stress response-dependent embryonic lethality [bulk RNA-seq]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe mechanisms that balance a robust antiviral defense with tissue tolerance at the maternal-fetal interface under physiological conditions remain largely unknown.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279579)

---

### 40. GSE279352 Adar1 as a placental innate immune rheostat to prevent endogenous dsRNA-induced integrated stress response-dependent embryonic lethality [RIP-seq]

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€carcinomaã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : OtherOrganism : Mus musculusThe mechanisms that balance a robust antiviral defense with tissue tolerance at the maternal-fetal interface under physiological conditions remain largely unknown.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279352)

---

### 41. GSE279053 Adar1 as a placental innate immune rheostat to prevent endogenous dsRNA-induced integrated stress response-dependent embryonic lethality

**åŒ¹é…å…³é”®è¯**ï¼šcancerã€carcinomaã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe mechanisms that balance a robust antiviral defense with tissue tolerance at the maternal-fetal interface under physiological conditions remain largely unknown.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279053)

---

### 42. GSE217603 NKT cells contribute to alleviating lung metastases in adenoid cystic carcinoma

**åŒ¹é…å…³é”®è¯**ï¼štumorã€carcinomaã€scRNAã€scDNAã€scATACã€genomeã€genomics  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Ge-xuan Feng ; Meng-jiao ZhouSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThrough CD4 and CD8 immunohistochemical analysis, we systematically established immune desert, exclusion, and inflammatory types in SACC primary lesions and lung metastases. Notably, the majority of lung metastases exhibited immune inflammatory types in contrast to the common desert type in primary SACC tissue. Tissue type rather than MYB-NFIB fusion should be a key factor causing differences in the immune environment. At the single-cell level, we demonstrated the presence of a small amount of anergy T cell types and a few elevated cytokines in the primary inflammatory tissues without MYB-NFIB fusion; and a large amount of myeloid-derived suppressor cells (MDSCs), a small amount of activated CD8+ NKT-like cells and substantially elevated cytokines in the primary exclusion tissues with MYB-NFIB fusion. In contrast, in the inflammatory metastatic lung tissues without MYB-NFIB fusion, small numbers of memory CD4+ and CD8+ cells were presented, but anergy CD8+ NKT-like cells and only CCL28 were elevated. Moreover, validated by immunodeficient nude mice, NKT cells are the remarkable effector cells in reducing lung metastasis, but required advance activation by a low invasive SACC cell line with higher human leukocyte antigen (HLA)-A, -B, and C expression induction.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217603)

---

### 43. GSE186837 A 3D in vitro mouse ovarian follicle culture system preserves molecular signatures of ovulation for studying ovulation biology and novel non-hormonal discovery

**åŒ¹é…å…³é”®è¯**ï¼štumorã€cancerã€oncologyã€lymphomaã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€metabolomeã€Seuratã€epigenomeã€clustering  
**æ¥æº**ï¼šGEO  
**ä½œè€…**ï¼šWed, 29 Oct 2025 00:00:00 -0400  
**å‘å¸ƒæ—¶é—´**ï¼šContributors : Jiyang Zhang ; Brittany A Goods ; Pawat Pattarawat ; Yingzheng Wang ; Tessa Haining ; Qiang Zhang ; Alex K Shalek ; Francesca E Ducan ; Teresa K Woodruff ; Shuo XiaoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWe previously established an alginate hydrogel-based 3D encapsulated in vitro follicle growth (eIVFG) system to culture mouse and human immature follicles in vitro. The alginate encapsulation maintained the 3D architecture of follicles and support their growth from the secondary to the antral stage to acquire maturation. Upon the stimulation of human chorionic gonadotropin (hCG), a LH analog, the grown antral follicle from eIVFG was able to rupture, undergo cumulus cell expansion, and ovulate a fertilizable metaphase II (MII) oocytes. We have also demonstrated that mouse follicles cultured using eIVFG preserved dynamic transcriptomic profile of many key genes that are essential for gonadotropin-dependent folliculogenesis, such as genes related to gonadotropin hormone receptors and ovarian steroidogenesis. However, it is unknown whether these follicles preserve molecular signatures of ovulation, which would enable this system to serve as a truly scalable and highly controllable system for nominating therapeutic and contraceptive candidates. In the present study, we treated mouse mature follicles from eIVFG with hCG to induce in vitro ovulation. Follicles were collected at 0, 1, 4, and 8 hours post-hCG for single-follicle RNA sequencing (RNA-seq) analysis. Our results showed that follicles grown from eIVFG preserve key ovulatory genes and signaling pathways.  
**é“¾æ¥**ï¼š[é˜…è¯»åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186837)

---

## ğŸ·ï¸ å…³é”®è¯ç»Ÿè®¡

- scRNAï¼š40 æ¬¡
- cancerï¼š33 æ¬¡
- genomeï¼š32 æ¬¡
- scDNAï¼š30 æ¬¡
- scATACï¼š28 æ¬¡
- genomicsï¼š28 æ¬¡
- Seuratï¼š28 æ¬¡
- tumorï¼š23 æ¬¡
- spatialï¼š23 æ¬¡
- histoneï¼š21 æ¬¡
- RNAseqï¼š17 æ¬¡
- Hi-Cï¼š17 æ¬¡
- RNA-seqï¼š16 æ¬¡
- Scanpyï¼š16 æ¬¡
- Visiumï¼š14 æ¬¡
- carcinomaï¼š13 æ¬¡
- ATAC-seqï¼š13 æ¬¡
- spatiallyï¼š12 æ¬¡
- proteomeï¼š11 æ¬¡
- DNA-seqï¼š11 æ¬¡
- R packageï¼š9 æ¬¡
- ChIP-seqï¼š8 æ¬¡
- single.cellï¼š7 æ¬¡
- methylationï¼š7 æ¬¡
- proteomicsï¼š6 æ¬¡
- clusteringï¼š6 æ¬¡
- epigeneticï¼š5 æ¬¡
- epigenomeï¼š5 æ¬¡
- sequencingï¼š4 æ¬¡
- leukemiaï¼š3 æ¬¡
- oncologyï¼š3 æ¬¡
- metabolomeï¼š3 æ¬¡
- pathwayï¼š2 æ¬¡
- enrichmentï¼š2 æ¬¡
- single-cellï¼š1 æ¬¡
- lymphomaï¼š1 æ¬¡

---

*æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-10-29 08:53*